As of 2024-12-13, the Intrinsic Value of Surmodics Inc (SRDX) is
3.75 USD. This SRDX valuation is based on the model Discounted Cash Flows (Growth Exit 10Y).
With the current market price of 39.99 USD, the upside of Surmodics Inc is
-90.60%.
The range of the Intrinsic Value is 1.82 - 19.50 USD
SRDX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(3.55) - (0.88) |
(1.17) |
-102.9% |
| DCF (Growth 10y) |
1.82 - 19.50 |
3.75 |
-90.6% |
| DCF (EBITDA 5y) |
5.35 - 8.45 |
6.65 |
-83.4% |
| DCF (EBITDA 10y) |
7.96 - 13.28 |
10.17 |
-74.6% |
| Fair Value |
-4.04 - -4.04 |
-4.04 |
-110.11% |
| P/E |
(29.02) - (28.91) |
(28.88) |
-172.2% |
| EV/EBITDA |
3.93 - 5.40 |
4.52 |
-88.7% |
| EPV |
2.25 - 2.75 |
2.50 |
-93.7% |
| DDM - Stable |
(13.66) - (141.78) |
(77.72) |
-294.4% |
| DDM - Multi |
(1.62) - (13.04) |
(2.88) |
-107.2% |
SRDX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
570.66 |
| Beta |
0.47 |
| Outstanding shares (mil) |
14.27 |
| Enterprise Value (mil) |
564.10 |
| Market risk premium |
4.60% |
| Cost of Equity |
6.33% |
| Cost of Debt |
7.00% |
| WACC |
6.27% |